Recruiting studies: Staphylococcal Bacteraemia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Dalbavancin Versus Standard Antibiotic Therapy for Catheter-related Bloodstream Infections Due to Staphylococcus Aureus
Phase 3 · 2 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05117398 Linezolid Plus Standard of Care
NA · 12 location(s) · University Hospital, Basel, Switzerland · NCT06958835 Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia
Phase 2 · 6 location(s) · Todd C. Lee MD MPH FIDSA · NCT04886284 Comparison of Cloxacillin and Benzylpenicillin in Penicillin Susceptible S. Aureus Bacteraemia
Phase 4 · 1 location(s) · Region Skane · NCT06726395 Staphylococcus Aureus Network Adaptive Platform Trial
Phase 4 · 161 location(s) · University of Melbourne · NCT05137119 Early Intravenous to Oral Antibiotic Switch in Uncomplicated Staphylococcus Aureus Bacteraemia
Phase 3 · 12 location(s) · Clinical Research Centre, Malaysia · NCT06336824 Echocardiography Versus no Echocardiography in S. Aureus Bacteraemia and VIRSTA Score < 3
NA · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06457386

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.